0 followers
Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.
Mark P. Lappe
Kura Oncology
18 followers
REVOLUTION Medicines
5 followers
Immunovant
5 followers
Relay Therapeutics
1 follower
Volastra
1 follower
Eikon Therapeutics
1 follower
Scribe Therapeutics
1 follower
Thermo Fisher Scientific
167 followers
Genentech
150 followers
Gilead Sciences
128 followers
Illumina
67 followers
Explore companies